Impact of calcium antagonists on the cardiovascular system. Experience with lacidipine

Drugs

Volumn 57, Issue SUPPL. 1, 1999, Pages 11-17

  Kuschnir, Emilio ^a,b  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Hospital Nacional de Clinicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DIPYRIDAMOLE; LACIDIPINE; NIFEDIPINE; NITRENDIPINE;

ADULT; AGE; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY VASCULAR RESISTANCE; DIASTOLE; DRUG CHOICE; DRUG EFFECT; EXERCISE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; SYSTOLE; VASCULAR RESISTANCE; VASODILATATION;

ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR SYSTEM; DIHYDROPYRIDINES; HUMANS; HYPERTENSION;

EID: 0032822226     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199957001-00002     Document Type: Conference Paper

References (26)

1. Nigro D, Vergottini C, Campo I, et al. Epidemiología de la HTA en Córdoba. XV InterAmerican Congress of Cardiology; 1995 Diciembre 6-9: Santiago de Chile. Revista de Cardiologia 1995; 14: 187-8
2. Staessen JA, Fagard R, Thijs L, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64
3. Hansson I, Zanchetti A, Carruthers SG, et al. Effects of intensive BP lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-62
4. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14 (10): 1237-45
5. Kuschnir E, Sgammini H, Castro R, et al. Patrones hemodinámicos en pacientes gerontes con hipertensión arterial [abstract]. Pt 1. Función sistólica. Medicina 1996; 56 SII: 24
6. Kuschnir E, Castro R, Oller Martinez, et al. Patrones hemodinámicos en pacientes gerontes con hipertensión arterial, Pt II. Función diastólica y circulación periférica [abstract]. Medicina 1996; 56 SII: 25
7. Kuschnir E, Castro R, Bendersky M, et al. Hemodynamic effects of nitrendipine on systolic ventricular function, diastolic ventricular function and peripheral circulation in essential hypertension. J Cardiovasc Pharmacol 1988; 12 Suppl. 4: S36-44
8. Kuschnir E, Castro R, Bendersky M, et al. Rest and effort hemodynamic effects of nisoldipine in essential hypertension (abstract). Fourth European Meeting of Hypertension: 1989 Jun 18; Milan, Italy. S72: 449
9. Zanchetti A, Lacidipine. The Monograph. Milan: Adis International, 1997
10. Ghiadoni L, Taddei S, Magagna A, et al. Effect of lacidipine on endothelial function in hypertensive patients. Am J Hypertens 1996; 9 (Pt 2): 155
11. Arcaro G, Alberiche M, Targher G, et al. Functional endothelial abnormalities in femoral artery of patients with NIDDM and hypertension. 56th Scientific Meeting of the American Diabetes Society; 1996 Jun 8-11: San Francisco
12. Levenson JA, Simon AC, Safar ME. Vasodilatation of small and large arteries in hypertension. J Cardiovasc Pharmacol 1985; 7 Suppl. 2: S115-20
13. Levenson JA, Simon A. Heterogeneity of response of peripheral arteries to antihypertensive drugs in essential hypertension. Basic effects and functional consequences. Drugs 1988; 35 Suppl. 5: 34-9
14. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65
15. Weber KT, Anversa P, Armstrong PW, et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 1992; 20: 3-16
16. Betoechi S, Chiariello M. Effects of calcium antagonists on left ventricular structure and function. J Hypertens 1993; 11 Suppl. 1: S33-37
17. Lopriore V, Corbascio N, Corbascio P. Echocardiography evaluation of a new calcium antagonist's effects on left ventricular mass [abstract]. 5th International Symposium of Calcium Antagonists: Pharmacology and Clinical Research; 1991 Sep 25-28: Houston, 98
18. Leonetti G, Salvi S. A long-term study comparing lacidipine and nifedipine SR in hypertensive patients: safety data. J Cardiovasc Pharmacol 1994; 23 Suppl. 5: S108-10
19. Sheiban I, Arosio E, Montesi G, et al. Remodelling of left ventricular geometry and function induced by lacidipine and nifedipine SR in mild-to-moderate hypertension. J Cardiovasc Pharmacol 1991; 17 Suppl. 4: S68-74
20. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 1996; 335 (15): 1107-14
21. Kuschnir E, Castro R, Sgammini H, et al. Cambios hemodinámicos en la función sistólica, diastólica y la circulación perilérica inducidas por Amlodipina en pacientes con hipertension esencial asociada a disfunción ventricular izquierda. Rev Argen Cardiol 1996; 64 Suppl. IV: 11-7
22. De Vries RJM, Dunselman PHJM, Chin Kon Sung UG, et al. Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure. Heart 1996; 75: 159-64
23. Russo G, Tamburino C, Aiello R, et al Effects of chronic lacidipine in patients with mild-moderate congestive heart failure (CHF) [abstract]. European Meeting of Cardiology and Cardiosurgery; 1993 Sep 27-29; Corfu
24. Strauer BE, Schwartzkopff B. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function and coronary reserve. Am J Hypertens 1998; 11: 879-81
25. Camiei P, Palombo C, Gistri R, et al. Effect of lacidipine on coronary vasodilator reserve in hypertensive patients: a study with positron tomography. Am J Hypertens 1991; 4: 57A
26. Soma MR, Corsini A, Paoletti R, et al. Calcium antagonists in atherosclerosis: focus on lacidipine. Res Clin Forums 1994; 16:43-53